Abstract
Evonik has purchased the German start-up JeNaCell, which makes biotechnologically derived cellulose for medical applications. Evonik’s venture capital arm invested in JeNaCell in 2015 and now plans to pair the firm with its Resomer bioresorbable polymers, used in medical implants. JeNaCell is a spinoff of the Friedrich Schiller University of Jena . Its films are being used as dressings for chronic wounds, surgical wounds, and burns.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
